Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
ST. LOUIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has established the first robotic center for the treatment of cardiac arrhythmias in Latvia and has successfully treated initial patients with the Genesis Robotic Magnetic Navigation System.
Covered in this story
Call it yourself
No calls on $STXS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Stereotaxis Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.